Study Points
- Back to Course Home
- Participation Instructions
- Review the course material online or in print.
- Complete the course evaluation.
- Review your Transcript to view and print your Certificate of Completion. Your date of completion will be the date (Pacific Time) the course was electronically submitted for credit, with no exceptions. Partial credit is not available.
Study Points
Click on any objective to view test questions.
- Describe cardiac conduction and the components of an ECG waveform.
- Use your knowledge of the pathophysiology of atrial fibrillation, including key defining characteristics, to differentiate it from other arrhythmias and predict impact on normal functioning.
- Outline common cardiac and noncardiac causes of atrial fibrillation.
- List key clinical data, including subjective symptoms, past medical history, physical assessment findings, and diagnostic/laboratory tests, important to obtain when assessing a patient with atrial fibrillation.
- Identify key components that should be considered in the development of the medical plan of care, including the issue of generic drug substitution.
- Compare and contrast antiarrhythmic medications appropriate to use for acute and chronic rate control for patients with atrial fibrillation.
- Outline the use of pharmacologic therapy in the restoration of normal sinus rhythm, including indications for use and procedure for administration.
- Describe electrical cardioversion, including indications and pre- and postprocedure care.
- Discuss antiarrhythmic medications that may be used to maintain normal sinus rhythm in a patient following successful spontaneous, electrical, or pharmacologic cardioversion.
- Select appropriate pharmacologic measures that may be used to reduce risk of thromboembolic events in persons with atrial fibrillation.
- Discuss the use of radiofrequency ablation of the atrioventricular (AV) node in the clinical management of atrial fibrillation.
- Describe the causes and recommended management of atrial fibrillation in adult patients following coronary artery bypass graft surgery and in patients with Wolff-Parkinson-White syndrome.
- Using simulated case study data, develop a best practice strategy for the clinical management of atrial fibrillation.
In the normal heart, the speed of conduction is slowed in the
A prolonged QT interval indicates
Of the following, which is a key defining characteristic of atrial fibrillation?
A key characteristic that can differentiate AV nodal re-entrant tachycardia from atrial fibrillation is
Cardiac problems linked to the development of atrial fibrillation include which of the following?
One noncardiac cause linked to the development of atrial fibrillation is
A physical assessment finding commonly associated with atrial fibrillation is
The initial goal for a patient with atrial fibrillation with a rapid ventricular response is
To receive FDA approval, a generic medication must meet all of the following criteria, EXCEPT:
Which of the following is a recommendation with regard to the use of generic medications for antiarrhythmic therapy?
For persons in atrial fibrillation with a rapid ventricular response, the usual IV bolus dose of diltiazem is
Which of the following statements is TRUE regarding the use of esmolol in atrial fibrillation?
A drug of choice for chronic rate control for persons in atrial fibrillation who also have an active lifestyle is
Severe digitalis toxicity may be reversed by the use of
Of the following, which statement most accurately describes the action of ibutilide?
The treatment of choice for torsades de pointes is
What is the desired rate of ibutilide administration via volumetric pump?
One toxic effect associated with amiodarone administration is
Electrical cardioversion is the treatment of choice for persons with
Prior to electrical cardioversion, a patient should be adequately anticoagulated with an INR maintained between 2.0–3.0 for
Because it can cause torsades de pointes, sotalol is NOT recommended to be administered in doses in excess of
The drug of choice for treatment of atrial fibrillation that has no identifiable cause is
For a CHA2DS2-VASc score of 0, the recommended antithrombotic approach is
Which of the following is an indication for radiofrequency ablation of the AV node?
Which of the following interventions represents appropriate care following electrophysiology testing?
The recommended postoperative therapy to prevent atrial fibrillation in patients who have undergone coronary artery bypass graft surgery is administration of
ECG characteristics associated with Wolff-Parkinson-White syndrome include
The initial drug of choice for the management of atrial fibrillation in Wolff-Parkinson-White syndrome is
In the case study of acute-onset atrial fibrillation, Patient D's risk factors for the development of atrial fibrillation include
A QTc interval of 580 msec is
- Back to Course Home
- Participation Instructions
- Review the course material online or in print.
- Complete the course evaluation.
- Review your Transcript to view and print your Certificate of Completion. Your date of completion will be the date (Pacific Time) the course was electronically submitted for credit, with no exceptions. Partial credit is not available.